Figure 3From: Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)28-Day all-cause mortality for PROWESS Patients meeting the Annane enrollment criteria. Steroids received at baseline and/or during the infusion period. AEC = Annane enrollment criteria; DrotAA, drotrecogin alfa (activated); PROWESS, Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis.Back to article page